BECKHAM
17-11-2015, 06:12 AM
A life-extending breast cancer drug will not be routinely offered on the NHS in England and Wales because it is still too expensive, says the watchdog NICE.
for more .... (http://www.bbc.co.uk/news/health-34831197#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa)
for more .... (http://www.bbc.co.uk/news/health-34831197#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa)